BETA: Please send your feedback!

PTC Therapeutics

NAS:PTCT

Biotechnology

$2.14bn
SMALL cap
$37.19 (1.58%)
8.9259%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
website

Headquarters

100 Corporate Court
South Plainfield, NJ 07080-2449

Executives

Name Title Gender
Michael Schmertzler, MBA Chairman Male
Stuart W. Peltz, PhD Chief Executive Officer & Class I Director Male
Mark Elliott Boulding Secretary, Chief Legal Officer & Executive VP Male
Allan Steven Jacobson, PhD Independent Class III Director Male
Martin Rexroad Senior Vice President-Human Resources Male
Jane Baj Head-Investor Relations Female
Neil Gregory Almstead, PhD Executive VP-Research, Operations & Technology Male
Shane William Charles Kovacs, CFA, MBA CFO & Head-Corporate Development Male
Tuyen Ong, MD, MBA Chief Medical Officer null

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

PTC Therapeutics - Competitors and Related Companies

How PTC Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.

PTC Therapeutics

NAS:PTCT

Biotechnology

$2.14bn
SMALL cap
$37.19 (1.58%)
8.9259%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…